My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 293

    1.

    Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

    De Mulder PH, Seynaeve C, Vermorken JB, van Liessum PA, Mols-Jevdevic S, Allman EL, Beranek P, Verweij J.

    Ann Intern Med. 1990 Dec 1;113(11):834-40.PMID: 2146911 [PubMed - indexed for MEDLINE]Related articles

    2.

    A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy.

    Ahn MJ, Lee JS, Lee KH, Suh C, Choi SS, Kim SH.

    Am J Clin Oncol. 1994 Apr;17(2):150-6.PMID: 8141107 [PubMed - indexed for MEDLINE]Related articles

    3.

    A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.

    Bonneterre J, Chevallier B, Metz R, Fargeot P, Pujade-Lauraine E, Spielmann M, Tubiana-Hulin M, Paes D, Bons J.

    J Clin Oncol. 1990 Jun;8(6):1063-9.PMID: 2140854 [PubMed - indexed for MEDLINE]Related articles

    4.

    Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.

    Gebbia V, Testa A, Valenza R, Cannata G, Tirrito ML, Gebbia N.

    Cancer. 1995 Nov 15;76(10):1821-8.PMID: 8625054 [PubMed - indexed for MEDLINE]Related articles

    5.

    A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.

    Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, Gandara D, Hesketh P, Khojasteh A, Harker G, et al.

    J Clin Oncol. 1991 May;9(5):721-8.PMID: 1826739 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

    Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, Pujade-Lauraine E, Paule B, Paes D, Bons J.

    N Engl J Med. 1990 Mar 22;322(12):816-21.PMID: 2137902 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.

    [No authors listed]

    J Clin Oncol. 1997 Jan;15(1):124-30.PMID: 8996133 [PubMed - indexed for MEDLINE]Related articles

    8.

    Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.

    Kris MG, Tyson LB, Clark RA, Gralla RJ.

    Cancer. 1992 Aug 15;70(4 Suppl):1012-6. Review.PMID: 1386282 [PubMed - indexed for MEDLINE]Related articles

    9.

    A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.

    Olver I, Paska W, Depierre A, Seitz JF, Stewart DJ, Goedhals L, McQuade B, McRae J, Wilkinson JR.

    Ann Oncol. 1996 Nov;7(9):945-52.PMID: 9006746 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.

    Gandara DR, Harvey WH, Monaghan GG, Perez EA, Stokes C, Bryson JC, Finn AL, Hesketh PJ.

    Semin Oncol. 1992 Aug;19(4 Suppl 10):67-71.PMID: 1387253 [PubMed - indexed for MEDLINE]Related articles

    11.

    Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

    Smyth JF, Coleman RE, Nicolson M, Gallmeier WM, Leonard RC, Cornbleet MA, Allan SG, Upadhyaya BK, Bruntsch U.

    BMJ. 1991 Dec 7;303(6815):1423-6.PMID: 1837743 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.

    Malik I, Moid I, Khan Z, Hussain M.

    Am J Clin Oncol. 1999 Apr;22(2):126-30.PMID: 10199444 [PubMed - indexed for MEDLINE]Related articles

    13.

    Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.

    Navari RM, Madajewicz S, Anderson N, Tchekmedyian NS, Whaley W, Garewal H, Beck TM, Chang AY, Greenberg B, Caldwell KC, et al.

    J Clin Oncol. 1995 Sep;13(9):2408-16.PMID: 7666101 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.

    Bhatia A, Tripathi KD, Sharma M.

    Indian J Med Res. 2003 Jul;118:33-41.PMID: 14748464 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.

    Bhatia A, Tripathi KD, Sharma M.

    Indian J Med Res. 2004 Sep;120(3):183-93.PMID: 15489556 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.

    Sorbe BG.

    Semin Oncol. 1994 Oct;21(5 Suppl 9):20-6.PMID: 9113123 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy.

    Smith DB, Newlands ES, Rustin GJ, Begent RH, Howells N, McQuade B, Bagshawe KD.

    Lancet. 1991 Aug 24;338(8765):487-90.PMID: 1714532 [PubMed - indexed for MEDLINE]Related articles

    18.

    A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.

    Chevallier B, Cappelaere P, Splinter T, Fabbro M, Wendling JL, Cals L, Catimel G, Giovannini M, Khayat D, Bastit P, Claverie N.

    Support Care Cancer. 1997 Jan;5(1):22-30.PMID: 9010986 [PubMed - indexed for MEDLINE]Related articles

    19.

    Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.

    [No authors listed]

    Lancet. 1992 Jul 11;340(8811):96-9.PMID: 1352024 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.

    Lee CW, Suh CW, Lee JS, Lee KH, Cho GY, Kim SW, Kim SH.

    J Korean Med Sci. 1994 Oct;9(5):369-75.PMID: 7702784 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity